Clinical Testing. If SMI desires to conduct any clinical testing of the Monitor, where the data from such testing is expected to be presented at a public forum or be published, SMI shall advise Aspect and no such clinical testing shall occur unless Aspect shall first have approved the protocols for such clinical testing. Aspect shall not unreasonably delay or withhold its approval of such clinical testing.
Appears in 2 contracts
Sources: Distribution and License Agreement (Aspect Medical Systems Inc), Distribution and License Agreement (Aspect Medical Systems Inc)